-
Mashup Score: 02025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - 4 month(s) ago
Read the full article here
Tweet
Nephrology With Joel Topf, MD
NephrologyDr. Topf is an assistant clinical professor of medicine at Oakland University William Beaumont School of Medicine, creator and host of the Freely Filtered and Channel Your Enthusiasm podcasts, creator of the Precious Bodily Fluids blog, and co-creator of NephMadness and NephJC.
-
Mashup Score: 0#NephMadness 2025: Meet the Gamemakers - 4 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0Mapping the effectiveness and risks of GLP-1 receptor agonists - 3 month(s) ago
Read the full article here
Tweet-
Cool study that leverages the VA EHR to look for all of the effects, good and bad, of GLP1ra. Lots of good, news, little bad, though some of it unexpected.
Pros: Shock, aspiration pneumonia, hep[atic failure, respiratory failure, cardiac arrest, bulemia, schizophrenia, hemorrhagic stroke, pulmonary hypertension and on and on and on.
Cons, besides the expected GI side effects there were increased risk musculoskeletal complaints, kidney stones, and headache.
-
-
Mashup Score: 0GLP-1s: Good News, Bad News - 3 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0GLP1ra Study Tweetorial - 3 month(s) ago
Read the full article here
Tweet
-
Mashup Score: 0
Read the full article here
Tweet
Last week, KDIGO published the inaugural guideline on ADPKD, their first guideline for a rare kidney disease. Look for NephJC to deep dive into the guideline in the coming months.